2HRA 📈 H&R GmbH & Co. KGaA - Overview
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000A2E4T77
2HRA: Chemical, Pharmaceutical, Plastics, Lubricants, Oils, Waxes, Emulsions
H&R GmbH & Co. KGaA engages in the manufacture and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts. It operates in three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment manufactures and distributes paraffins, white oils, plasticizers, base oils, lubricants, and other crude oil-based specialty products, as well as by-products, such as feedstocks and bunker fuels. The ChemPharm Sales segment processes and distributes plasticizers, wax emulsions, paraffins, and other crude oil-based specialty products. The Plastics segment develops, manufactures, and sells precision plastic parts, components, and medical consumables for medical technology, automotive, and other traditional industries. It provides emulsifiers and bases, waxes and emulsions, petroleum jellies, water-based waxes and oil-emulsions, motor and process oils, cable filling compounds. The company was formerly known as H&R Aktiengesellschaft and changed its name to H&R GmbH & Co. KGaA in August 2016. The company was founded in 1919 and is headquartered in Salzbergen, Germany Web URL: https://www.hur.com
Additional Sources for 2HRA Stock
2HRA Stock Overview
Market Cap in USD | 133m |
Sector | Basic Materials |
Industry | Chemicals |
GiC Sub-Industry | Commodity Chemicals |
IPO / Inception |
2HRA Stock Ratings
Growth 5y | -47.1% |
Fundamental | 10.2% |
Dividend | 25.0% |
Rel. Strength Industry | -6279 |
Analysts | - |
Fair Price Momentum | 2.87 EUR |
Fair Price DCF | 15.14 EUR |
2HRA Dividends
Dividend Yield 12m | 3.05% |
Yield on Cost 5y | 1.95% |
Annual Growth 5y | % |
Payout Consistency | 44.9% |
2HRA Growth Ratios
Growth Correlation 3m | -92.6% |
Growth Correlation 12m | -76.6% |
Growth Correlation 5y | -33.8% |
CAGR 5y | -8.54% |
CAGR/Mean DD 5y | -0.25 |
Sharpe Ratio 12m | -1.52 |
Alpha | -48.03 |
Beta | 0.59 |
Volatility | 21.35% |
Current Volume | 6.2k |
Average Volume 20d | 4.6k |
What is the price of 2HRA stocks?
As of December 27, 2024, the stock is trading at EUR 3.28 with a total of 6,208 shares traded.
Over the past week, the price has changed by -2.38%, over one month by -4.93%, over three months by -13.68% and over the past year by -29.07%.
As of December 27, 2024, the stock is trading at EUR 3.28 with a total of 6,208 shares traded.
Over the past week, the price has changed by -2.38%, over one month by -4.93%, over three months by -13.68% and over the past year by -29.07%.
Is H&R GmbH & Co. KGaA a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, H&R GmbH & Co. KGaA is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 10.18 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of 2HRA as of December 2024 is 2.87. This means that 2HRA is currently overvalued and has a potential downside of -12.5%.
Neither. Based on ValueRay Fundamental Analyses, H&R GmbH & Co. KGaA is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 10.18 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of 2HRA as of December 2024 is 2.87. This means that 2HRA is currently overvalued and has a potential downside of -12.5%.
Is 2HRA a buy, sell or hold?
H&R GmbH & Co. KGaA has no consensus analysts rating.
H&R GmbH & Co. KGaA has no consensus analysts rating.
What are the forecast for 2HRA stock price target?
According to ValueRays Forecast Model, 2HRA H&R GmbH & Co. KGaA will be worth about 3.1 in December 2025. The stock is currently trading at 3.28. This means that the stock has a potential downside of -5.49%.
According to ValueRays Forecast Model, 2HRA H&R GmbH & Co. KGaA will be worth about 3.1 in December 2025. The stock is currently trading at 3.28. This means that the stock has a potential downside of -5.49%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 5.8 | 76.8% |
Analysts Target Price | - | - |
ValueRay Target Price | 3.1 | -5.5% |